In addition, Ono et al. observed that in their cases, there was MMR protein deficiency and that this was significantly associated with PD-L1 expression and the presence of tumour-infiltrating lymphocytes (CD8+), demonstrating also that EDC could be a target for immune checkpoint inhibitors. This evidence concerns the gene CD274 and neoplasm.